Citi Downgrades Lam Research (LRCX) to Sell
More News related to LRCX
- StockPreacher.com Issues Trading Overview for Aixtron Aktiengesellschaft
- Lam Research Corporation Announces Participation at Credit Suisse Annual Technology Conference
- Caris & Co Upgrades Lam Research (LRCX) to Above Average
- Lam Research Corporation Announces Financial Results for the Quarter Ended September 27, 2009
- Trading Radar for 10/21: Boeing (BA), eBay (EBAY), Wells Fargo (WFC), US Bancorp (USB), Eli Lilly (ELY), St. Jude Medical (STJ) Report
More News related to Downgrades
- IA Global (IAO) Reports Preliminary Results for the Quarter Ended Sept. 2009
- Barnes & Noble (BKS) Reports In-Line Loss of $0.30; Lowers FY Guidance
- AVANIR Pharma (AVNR) Posts Q4 Loss of 9c, Wider than Anticipated
- Daktronics (DAKT) Tops Q2 Views by 10c
- Borders Group (BGP) Posts Q3 loss of $0.65, Wider than Expected
Citi downgrades Lam Research (Nasdaq: LRCX) from Hold to Sell. Price target increased by $1 to $32.
To see more analyst ratings on LRCX Click Here.
Lam Research Corporation engages in the design, manufacture, marketing, and service of semiconductor processing equipment used in the fabrication of integrated circuits.
Related Categories
DowngradesStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
